HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Steven R. Meyer Ivan M. Rebeyka David B. Ross Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyer, S. R. Articles by Ross, D. B. Search for Related Content PubMed PubMed Citation Articles by Meyer, S. R. Articles by Ross, D. B. Related Collections Congenital - cyanotic Transplantation - heart Valve disease

Eur J Cardiothorac Surg 2005;27:554-560
© 2005 Elsevier Science NL

Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation

^a Department of Surgery, University of Alberta Hospital and Stollery Children's Hospital, Edmonton, Alta., Canada
^b Histocompatability Laboratory, Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Edmonton, Alta., Canada
^c Department of Pediatrics, Stollery Children's Hospital, Edmonton, Alta., Canada

Received 31 August 2004; received in revised form 17 December 2004; accepted 23 December 2004.

^* Corresponding author. Address: Department of Surgery, Surgical Medical Research Institute, 1074 Pharmacy/Dentistry Building, University of Alberta, Edmonton, Alta., Canada T6G 2N8. Tel.: +1 780 407 8047; fax: +1 780 407 8054. (E-mail: srmeyer{at}ualberta.ca).

Objective: Cryopreserved allograft tissue used in the Norwood procedure for infants with hypoplastic left heart syndrome (HLHS) has the potential to cause marked immunologic sensitization which may complicate potential future heart transplantation, if required. The purpose of this study was to assess the anti-HLA antibody response to allograft patches used in the initial repair of HLHS. Methods: A prospective cohort study was conducted comparing the panel-reactive antibody levels (PRA) in 12 infants undergoing repair of HLHS with cryopreserved allograft patch to 10 infants undergoing arterial switch for transposition of the great arteries (no allograft tissue used). PRA for Class I (HLA-A, B, C) and Class II (HLA-DR, DQ) antibodies were assessed preoperatively and postoperatively using flow cytometry. Results: The two groups were well matched at the time of surgery (age, weight, gender). Infants in both groups received blood from multiple donors; however, the allograft group received significantly more (12±10 vs. 5±1 units; P<0.001). By 4 months, most infants receiving allograft tissue had become highly sensitized for both Class I PRA (62±40 vs. 0; P=0.002) and Class II PRA (49±42 vs. 2±3; P=0.022). This response continued to increase at 12 months: Class I PRA (79±21 vs. 0; P=0.008) and Class II PRA (66±27 vs. 5±6; P=0.008). Specificity analysis confirmed antibodies were specific for the donor allograft HLA type. In addition, infants who were coincidently HLA-matched with their allograft did not develop an elevated PRA. Conclusions: Allograft tissue used in the repair of HLHS is associated with profound donor specific immunologic sensitization in the majority of recipients and may complicate or jeopardize future transplantation. Methods to reduce the immunogenicity of cryopreserved allograft tissue used for arch reconstruction requires further investigation.

Key Words: Allograft tissue • Panel reactive antibody • Transplantation • Hypoplastic left heart syndrome

This article has been cited by other articles:

				C. A. Caldarone, O. Honjo, L. N. Benson, and G. S. Van Arsdell Modification of stage II procedure after hybrid palliation (bilateral pulmonary artery banding and ductal stenting) for hypoplastic left-sided heart syndrome: Modified arch reconstruction with retained stented ductus patch. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1588 - 1589. [Full Text] [PDF]

				C. A. Caldarone, L. Benson, H. Holtby, J. Li, A. N. Redington, and G. S. Van Arsdell Initial Experience With Hybrid Palliation for Neonates With Single-Ventricle Physiology Ann. Thorac. Surg., October 1, 2007; 84(4): 1294 - 1300. [Abstract] [Full Text] [PDF]

				V. O. Morell and P. A. Wearden Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Ann. Thorac. Surg., October 1, 2007; 84(4): 1312 - 1315. [Abstract] [Full Text] [PDF]

				M. Vicchio, A. Nava, and G. Caianiello Bovine jugular vein as aortic enlargement patch in the Norwood procedure J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 819 - 819. [Full Text] [PDF]

				S. R. Meyer, D. B. Ross, K. Forbes, L. E. Hawkins, A. M. Halpin, S. N. Nahirniak, J. M. Rutledge, I. M. Rebeyka, and P. M. Campbell Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1517 - 1523. [Abstract] [Full Text] [PDF]

				D. G. Healy, L. Nolke, and A. E. Wood Bovine jugular vein as a shaped alternative patch material for aortic augmentation in the Norwood procedure J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 567 - 568. [Full Text] [PDF]

				E. J. Lehr, G. R. Rayat, L. S. Desai, J. Y. Coe, G. S. Korbutt, and D. B. Ross Inbred or outbred? An evaluation of the functional allogenicity of farm sheep used in cardiac valve studies. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1156 - 1161. [Abstract] [Full Text] [PDF]

				S. R. Meyer, J. Nagendran, L. S. Desai, G. R. Rayat, T. A. Churchill, C. C. Anderson, R. V. Rajotte, J. R.T. Lakey, and D. B. Ross Decellularization reduces the immune response to aortic valve allografts in the rat J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 469 - 476. [Abstract] [Full Text] [PDF]